vs
HARVARD BIOSCIENCE INC(HBIO)与Rumble Inc.(RUM)财务数据对比。点击上方公司名可切换其他公司
Rumble Inc.的季度营收约是HARVARD BIOSCIENCE INC的1.1倍($27.1M vs $23.7M),HARVARD BIOSCIENCE INC净利率更高(-12.0% vs -120.8%,领先108.8%),HARVARD BIOSCIENCE INC同比增速更快(-3.3% vs -10.5%),HARVARD BIOSCIENCE INC自由现金流更多($-545.0K vs $-31.7M),过去两年Rumble Inc.的营收复合增速更高(15.2% vs -1.6%)
哈佛生物科学是一家全球生命科学设备开发商、制造商与销售商,其产品主要用于支撑科研开发与药物研发工作,目前该公司在纳斯达克上市,股票交易代码为HBIO。
Rumble Inc.是一家加美跨国企业,主营在线视频平台、网络托管及云服务,总部位于加拿大多伦多,美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立,云服务板块为Truth Social提供托管支持,其视频平台在美国保守派及极右翼用户群体中广受欢迎,属于“另类科技”阵营。
HBIO vs RUM — 直观对比
营收规模更大
RUM
是对方的1.1倍
$23.7M
营收增速更快
HBIO
高出7.1%
-10.5%
净利率更高
HBIO
高出108.8%
-120.8%
自由现金流更多
HBIO
多$31.2M
$-31.7M
两年增速更快
RUM
近两年复合增速
-1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $23.7M | $27.1M |
| 净利润 | $-2.8M | $-32.7M |
| 毛利率 | 59.7% | 5.5% |
| 营业利润率 | 7.2% | -131.1% |
| 净利率 | -12.0% | -120.8% |
| 营收同比 | -3.3% | -10.5% |
| 净利润同比 | -15916.7% | 86.2% |
| 每股收益(稀释后) | $-0.06 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HBIO
RUM
| Q4 25 | $23.7M | $27.1M | ||
| Q3 25 | $20.6M | $24.8M | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $21.8M | $23.7M | ||
| Q4 24 | $24.6M | $30.2M | ||
| Q3 24 | $22.0M | $25.1M | ||
| Q2 24 | $23.1M | $22.5M | ||
| Q1 24 | $24.5M | $17.7M |
净利润
HBIO
RUM
| Q4 25 | $-2.8M | $-32.7M | ||
| Q3 25 | $-1.2M | $-16.3M | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-50.3M | $-2.7M | ||
| Q4 24 | $18.0K | $-236.8M | ||
| Q3 24 | $-4.8M | $-31.5M | ||
| Q2 24 | $-2.9M | $-26.8M | ||
| Q1 24 | $-4.7M | $-43.3M |
毛利率
HBIO
RUM
| Q4 25 | 59.7% | 5.5% | ||
| Q3 25 | 58.4% | -1.8% | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.0% | -26.7% | ||
| Q4 24 | 57.1% | -14.2% | ||
| Q3 24 | 58.1% | -45.4% | ||
| Q2 24 | 57.2% | -58.8% | ||
| Q1 24 | 60.3% | -79.5% |
营业利润率
HBIO
RUM
| Q4 25 | 7.2% | -131.1% | ||
| Q3 25 | 1.0% | -113.6% | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -228.1% | -153.5% | ||
| Q4 24 | 0.0% | -80.1% | ||
| Q3 24 | -8.5% | -131.0% | ||
| Q2 24 | -9.0% | -172.7% | ||
| Q1 24 | -9.3% | -197.4% |
净利率
HBIO
RUM
| Q4 25 | -12.0% | -120.8% | ||
| Q3 25 | -6.0% | -65.7% | ||
| Q2 25 | -11.2% | — | ||
| Q1 25 | -231.2% | -11.2% | ||
| Q4 24 | 0.1% | -783.2% | ||
| Q3 24 | -21.9% | -125.9% | ||
| Q2 24 | -12.7% | -119.2% | ||
| Q1 24 | -19.1% | -244.1% |
每股收益(稀释后)
HBIO
RUM
| Q4 25 | $-0.06 | $-0.13 | ||
| Q3 25 | $-0.03 | $-0.06 | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $-1.14 | $-0.01 | ||
| Q4 24 | $0.01 | $-1.17 | ||
| Q3 24 | $-0.11 | $-0.15 | ||
| Q2 24 | $-0.07 | $-0.13 | ||
| Q1 24 | $-0.11 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $237.9M |
| 总债务越低越好 | $35.9M | — |
| 股东权益账面价值 | $13.7M | $274.8M |
| 总资产 | $80.1M | $336.8M |
| 负债/权益比越低杠杆越低 | 2.61× | — |
8季度趋势,按日历期对齐
现金及短期投资
HBIO
RUM
| Q4 25 | $8.6M | $237.9M | ||
| Q3 25 | $6.8M | $269.8M | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $5.5M | $301.3M | ||
| Q4 24 | $4.1M | $114.0M | ||
| Q3 24 | $4.6M | $132.0M | ||
| Q2 24 | $4.0M | $154.2M | ||
| Q1 24 | $4.3M | $183.8M |
总债务
HBIO
RUM
| Q4 25 | $35.9M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $36.4M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.6M | — |
股东权益
HBIO
RUM
| Q4 25 | $13.7M | $274.8M | ||
| Q3 25 | $14.1M | $302.2M | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $14.8M | $339.6M | ||
| Q4 24 | $63.3M | $-63.1M | ||
| Q3 24 | $65.3M | $166.1M | ||
| Q2 24 | $67.2M | $192.7M | ||
| Q1 24 | $68.8M | $210.7M |
总资产
HBIO
RUM
| Q4 25 | $80.1M | $336.8M | ||
| Q3 25 | $78.0M | $367.2M | ||
| Q2 25 | $80.1M | — | ||
| Q1 25 | $79.8M | $391.1M | ||
| Q4 24 | $126.6M | $195.3M | ||
| Q3 24 | $131.2M | $217.2M | ||
| Q2 24 | $128.9M | $243.2M | ||
| Q1 24 | $133.2M | $263.0M |
负债/权益比
HBIO
RUM
| Q4 25 | 2.61× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-96.0K | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | $-545.0K | $-31.7M |
| 自由现金流率自由现金流/营收 | -2.3% | -117.2% |
| 资本支出强度资本支出/营收 | 1.9% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.5M | $-70.8M |
8季度趋势,按日历期对齐
经营现金流
HBIO
RUM
| Q4 25 | $-96.0K | $-29.4M | ||
| Q3 25 | $1.1M | $-10.6M | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $3.0M | $-14.5M | ||
| Q4 24 | $1.7M | $-12.4M | ||
| Q3 24 | $-842.0K | $-19.1M | ||
| Q2 24 | $-846.0K | $-21.7M | ||
| Q1 24 | $1.4M | $-33.9M |
自由现金流
HBIO
RUM
| Q4 25 | $-545.0K | $-31.7M | ||
| Q3 25 | $877.0K | $-12.0M | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $2.5M | $-14.6M | ||
| Q4 24 | $1.4M | $-12.4M | ||
| Q3 24 | $-1.7M | $-19.9M | ||
| Q2 24 | $-1.7M | $-23.1M | ||
| Q1 24 | $758.0K | $-34.3M |
自由现金流率
HBIO
RUM
| Q4 25 | -2.3% | -117.2% | ||
| Q3 25 | 4.3% | -48.6% | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 11.4% | -61.7% | ||
| Q4 24 | 5.8% | -40.9% | ||
| Q3 24 | -7.8% | -79.5% | ||
| Q2 24 | -7.2% | -102.8% | ||
| Q1 24 | 3.1% | -193.3% |
资本支出强度
HBIO
RUM
| Q4 25 | 1.9% | 8.5% | ||
| Q3 25 | 1.0% | 5.7% | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 2.4% | 0.6% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 4.0% | 3.4% | ||
| Q2 24 | 3.5% | 6.1% | ||
| Q1 24 | 2.6% | 2.4% |
现金转化率
HBIO
RUM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 95.83× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |